FSP1 deficiency significantly inhibit AML progression and this process is mediated by the principal enzyme responsible for m5C deposition in RNA—NOP2/Sun RNA methyltransferase 2 (NSUN2) [87]. This evidence concerns the gene NSUN2 and acute myeloid leukemia.